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Abstract 
 
In the protein 4.1R gene, alternative first exons splice differentially to alternative 3’ splice 
sites far downstream in exon 2’/2 (E2’/2). We describe a novel intrasplicing mechanism by 
which exon 1A (E1A) splices exclusively to the distal E2’/2 acceptor via two nested splicing 
reactions regulated by novel properties of exon 1B (E1B). E1B behaves as an exon in the first 
step, using its consensus 5’ donor to splice to the proximal E2’/2 acceptor. A long region of 
downstream intron is excised, juxtaposing E1B with E2’/2 to generate a new composite acceptor 
containing the E1B branchpoint/pyrimidine tract and E2 distal 3’ AG-dinucleotide. Next, the 
upstream E1A splices over E1B to this distal acceptor, excising the remaining intron plus E1B 
and E2’ to form mature E1A/E2 product. We mapped branchpoints for both intrasplicing 
reactions and demonstrated that mutation of the E1B 5’ splice site or branchpoint abrogates 
intrasplicing. In the 4.1R gene, intrasplicing ultimately determines N-terminal protein structure 
and function. More generally, intrasplicing represents a new mechanism whereby alternative 
promoters can be coordinated with downstream alternative splicing. 
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Introduction 
Alternative pre-mRNA splicing is a critical regulator of eukaryotic gene expression that 
enables a relatively small number of genes to encode a much larger proteome.  Moreover, many 
alternatively spliced genes are regulated in a tissue-specific manner, so that the structure and 
function of the encoded protein isoforms can be tailored to the requirements of various 
differentiated cell types. Biochemical and computational studies have identified a number of 
trans-acting splicing factors, and cis-acting regulatory elements in the pre-mRNA, that work 
together to carry out specific alternative splicing programs during normal development. 
Although much remains to be learned about alternative splicing regulation, recent studies 
document significant progress in deciphering the splicing “code” that regulates the splicing 
efficiency of alternative exons. Several recent reviews summarize the state of the field in terms 
of understanding regulation in normal development, and in terms of the impact of aberrant 
splicing regulation in human disease (Black, 2003; Blencowe, 2006; Faustino and Cooper, 2003; 
Matlin et al., 2005). 
It is increasingly clear that many eukaryotic genes also possess multiple transcriptional 
promoters associated with alternative first exons (Baek et al., 2007; Cooper et al., 2006; Kim et 
al., 2005; Tan et al., 2006; Denoeud et al., 2007), a phenomenon that may be as common as 
alternative splicing of internal exons. Often these alternative first exons are located far upstream 
of the coding exons (Hong et al., 2006), raising questions as to how very long introns are 
accurately spliced. Moreover, there is considerable interest in understanding to what extent these 
5’ transcription decisions influence downstream alternative splicing events. Much has been 
written about the coupling of transcription and splicing processes (Bird et al., 2004; Das et al., 
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2006; Dye et al., 2006; Hirose and Manley, 2000; Listerman et al., 2006; Maniatis and Reed, 
2002), and a few studies have directly demonstrated that promoter identity can influence 
downstream alternative splicing (Auboeuf et al., 2004; Cramer et al., 1999; Cramer et al., 1997; 
Kornblihtt, 2005; Pagani et al., 2003). However, these processes remain poorly understood. 
The protein 4.1R gene (EPB41) provides an interesting model system in which to explore 
some of these issues mechanistically. In the human genome, this complex gene spans ~240kb 
and is comprised of 22 exons, at least 10 of which can be alternatively spliced (Conboy et al., 
1991; Huang et al., 1993; Parra et al., 2004; Schischmanoff et al., 1997; Baklouti et al., 1997).  
The 5’ region of the gene contains three mutually exclusive, alternative first exons designated 
E1A, E1B, and E1C (Figure 1A).  These exons are located far upstream of the coding exons (73-
100kb) and possess their own transcriptional promoters (Parra et al., 2003).  Most importantly, 
these first exons exhibit a unique and strictly observed splicing paradigm: transcripts initiated at 
the 5’-most exon (E1A) always splice to the distal 3’ acceptor located within exon 2 (E2), while 
E1C transcripts always choose the proximal one only 17 nucleotides (nt) upstream (Figure 1B). 
This splicing decision determines N-terminal protein structure, since translation start site AUG1 
is encoded in the alternatively spliced portion of E2. Transcripts including this sequence encode 
larger isoforms of 4.1R protein containing a long N-terminal headpiece, while those excluding it 
initiate translation farther downstream at AUG2 located in E4 (Figure 1C). The latter mRNAs 
encode smaller ~80kDa isoforms of protein that differ significantly in their affinity for binding 
partners in the red cell membrane (Nunomura et al., 2002).  Given this gene structure, cells can 
vary the ratio of N-terminal isoforms by controlling transcription at the upstream promoters. 
We are studying the molecular mechanism that coordinates upstream transcription events 
with downstream splicing events in the 4.1R gene.  Some of the key questions to be addressed 
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include: How does E1A selectively choose the distal 3’ acceptor when there is a another one only 
17 nt upstream? How is this event regulated across long distances? Since the splicing pattern is 
conserved across several vertebrate orders and is independent of tissue type (Parra et al., 2003; 
Tan et al., 2005), it appears not to require any cell type specific splicing factors. In this study, we 
present data indicating that E1A splicing is coordinated via a two-step mechanism utilizing an 
exon-like element that has an AG-independent upstream intron and exhibits both exonic and 
intronic features. Because the pathway involves nested splicing reactions first removing a large 
internal region of the intron, followed by resplicing over the same region using external splice 
sites to remove the remaining intron, the model resembles the “intrasplicing” mechanism 
proposed earlier (Ott et al., 2003). The intrasplicing model is supported by a series of 
experiments with minigene constructs that recapitulate intrasplicing in a manageable system and 
allow for analysis of essential regulatory motifs. This analysis reveals that intrasplicing is distinct 
from recursive splicing, another mechanism for stepwise removal of long introns (Burnette et al., 
2005; Hatton et al., 1998).  
 
Results 
Accurate E1A splicing to E2’/2 requires a downstream element mapping to the E1B region. 
The proximal 3’ splice acceptor site at E2’/2 is preceded by a typical pyrimidine tract and is 
predicted to function as a strong acceptor (Figure 1B); indeed, the proximal site is selected 
exclusively in all single-intron constructs examined to date (see below). The distal site, only 17nt 
downstream, is preceded by purines that apparently weaken its function. To study the molecular 
mechanism by which E1A selectively splices to the distal 3’ splice site ~100 kb downstream in 
E2’/2, we engineered a series of minigenes that recapitulate this coordinated splicing process in a 
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cell culture system (Figure 2). Construct pE1A-1 used the natural E1A promoter to drive 
expression of a small model pre-mRNA containing only E1A, E2’/2, and a few hundred 
nucleotides of flanking intron sequence.  This minimal construct was spliced incorrectly in 
transfected cells: E1A was joined exclusively to the proximal 3’ acceptor of E2 to generate a 
product that is slightly larger (Figure 3, lane 1) than the expected normal product due to the 
inclusion of E2’.  Multiple attempts at reconstituting proper E1A splicing to the distal 3’ splice 
site were unsuccessful until sequences extending ~7 kb downstream of E1A were included in the 
minigene (construct pE1A-2L).  This longer construct extended past exon 1B (E1B), a 
previously annotated alternative first exon that is rarely expressed among 4.1R clones in the 
genetic databases. E1A splicing in this context bypassed the proximal acceptor and instead was 
completely switched to the appropriate distal acceptor in E2’/2 (Figure 3, lane 2). This result 
suggested that element(s) several kilobases downstream of E1A, perhaps overlapping with E1B, 
are powerful determinants of its downstream splicing choice(s).  
In order to define the active element that promotes accurate E1A splicing, we systematically 
assayed a series of constructs spanning various portions of the intronic region between E1A and 
E1B. The most informative of these are diagrammed in Figure 2 (top panel), and assayed for 
splicing in Figure 3. Ultimately, construct pE1A-2 revealed that a specific 200 nt fragment was 
necessary and sufficient for proper E1A splicing (lane 3).  This element mapped ~6.5 kb 
downstream of E1A and encompassed E1B. DNA fragments of similar length, but shifted 100nt 
upstream or downstream, did not rescue proper E1A splicing (constructs pE1A-2a and pE1A-2b; 
lanes 4 and 5). These results suggested that multiple elements in the vicinity of E1B, including 
its 5’ splice site and sequences ≥100nt upstream, are required for proper splicing of E1A.  
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Proper E1A splicing does not require specific transcriptional regulatory elements but does 
require the E1B 5’ splice site.  
Transcriptional promoters can exert a significant influence on downstream splicing events 
(Kornblihtt, 2005).  To determine whether the natural E1A promoter region (Parra et al., 2003) is 
essential for correct downstream splicing, we tested E1A splicing in constructs expressed from 
several exogenous promoters. Minigenes that retained the E1B-associated splicing regulator, but 
were transcribed from a cytomegalovirus (CMV) promoter, an ankyrin promoter (Gallagher et 
al., 2000), or the natural 4.1R E1C promoter, all mimicked E1A splicing to the distal acceptor 
site at E2’/2 (Figure 4A, lanes 2 and 3). Because the latter two constructs also substituted a 
heterologous first exon for 4.1R-E1A, there appears to be no specific primary sequence 
requirement in the first exon. Together these results suggest that specific sequences in the 
proximal promoter and /or the first exon are not sufficient to determine downstream splicing 
preferences at E2’/2. Additional experiments demonstrated further that the E1B-associated 
regulatory element does not possess transcriptional enhancer activity when tested in a luciferase 
reporter construct (data not shown). Therefore, neither proximal transcriptional promoter 
elements nor distal transcriptional enhancer elements can account for E1A splicing specificity. 
Instead, it appears that the E1B region is the critical determinant that appears capable of 
mediating appropriate splicing independent of the identity of the upstream promoter / first exon. 
We next considered the possibility that the active element encompassing E1B might function 
via a splicing-based mechanism to promote proper E1A splicing.  To test whether the annotated 
E1B 5’ splice site plays a role in this process, we compared E1A splicing patterns in pre-mRNA 
constructs that contained either a normal (G/gtgagt) or a mutated (G/atgaat) 5’ splice site at E1B.  
Figure 4B shows that abolishing the 5’ splice site disrupted the proper splicing of E1A, causing it 
Parra et al., 2007 
8 
to switch predominantly to use of the proximal acceptor site at E2 to generate a PCR product that 
is larger (lane 3) than the correct product (lane 2). Control experiments revealed that a cryptic 5’ 
splice site (G/gtttga), located 10 nt downstream of the endogenous E1B 5’ splice site, could 
substitute for the natural 5’ splice site (data not shown). Together these results indicated that a 
functional 5’ splice site in the E1B region is essential for coupling of E1A to the distal acceptor 
site at E2, and led us to propose the splicing model presented below.     
The two-step intrasplicing hypothesis 
Based on similarities in splice site arrangement of the 4.1R gene 5’ region to the intrasplicing 
model proposed earlier on hypothetical grounds (Ott et al., 2003), we proposed a two step 
splicing mechanism that incorporates the requirement for the E1B-regulatory region. As shown 
in Figure 5A, this region of the 4.1R pre-mRNA contains two pairs of splice sites: an “internal” 
set comprising E1B 5’ (SD1) and the proximal 3’ acceptor site at E2 (SA1), and an “external” set 
represented by E1A 5’ (SD2) and the distal 3’ splice site at E2 (SA2). Sequential activation of 
the internal and then external splice site pairs can remove the entire intron in two steps and 
insure selection of SA2 in mature mRNA. A unique and essential feature of the model is the 
regulatory element that drives this process: it has specific features of both exons and introns that 
allow it to function in both capacities at different steps of intrasplicing. For that reason we 
designate this element as an “intraexon”; in the 4.1R gene this element has been annotated as a 
first exon, but its major function may be in intrasplicing. 
In the first step of the reaction, we hypothesize that E1B is recognized as an exon and uses its 
strong 5’ splice site to join E1B and E2’/2 via splice sites SD1 and SA1.  This reaction creates a 
lariat structure comprising the intronic region between E1B and E2, as well as a splicing 
intermediate with the overall structure E1A—intron—E1B/E2’/2.  The partially spliced 
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intermediate RNA no longer possesses the internal splice site pair (SD1 and SA1) or the natural 
branchpoint sequence upstream of E2, and the architecture of both E1B and E2’/2 has been 
completely altered by their juxtaposition to form a composite 3’ splice site for the second step of 
intrasplicing.  That is, the branchpoint and pyrimidine region of E1B are now coupled with the 
distal AG acceptor site of E2’/2, and the intraexon 1B behaves like an intron to promote splicing 
of E1A (SD2) to the remaining 3’ acceptor in E2’/2 (SA2).  Accordingly, the intraexon 
contributes a new branchpoint sequence to which the E1A 5’ splice site loops during lariat 
formation.  
To identify candidate regulatory motifs whose function could be experimentally assessed in 
splicing assays, we examined the primary nucleotide sequences of the E1B region (Figure 5B, 
upper panel).  In addition to its consensus 5’ splice site, E1B is preceded by intronic sequence 
that contains a candidate branchpoint, followed by a modest pyrimidine rich sequence (17/24 
pyrimidines) and two nonconsensus 3’ splice site dinucleotides TG and GG with no AG-
dinucleotides in the vicinity. The observation of two rare EST clones that exhibit utilization of 
these nonconsensus splice sites (BP364691 and BP315748) supports the notion that E1B can be 
recognized in an AG-independent manner to promote its splicing to E2’/2.  After the first step of 
intrasplicing, E1B is then juxtaposed with E2’ (shaded) to generate the sequence shown in the 
lower panel of Figure 5B. In this new structure, a novel composite 3’ splice site is composed of 
the branchpoint and pyrimidine tract of E1B and the distal AG-dinucleotide from E2’/2.  The 
predicted branchpoint would now be relatively far upstream of the 3’ splice site (~111nt), an 
unusual but not unprecedented arrangement (Gooding et al., 2006). Indeed, like other introns 
with distant branchpoints, the E1B region has an AG-exclusion zone that extends from the 
putative branchpoint to the distal E2 acceptor.  
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Experimental analysis of the intrasplicing model   
The intrasplicing model proposes that specific motifs associated with E1B, E2’/2, and E1A 
drive a two step process that proceeds through an obligatory intermediate RNA in which 
intraexon 1B is joined to E2’/2.  This structure can then serve as a direct precursor of the mature 
product by re-splicing at the external splice site pair SD2 and SA2 so as to join E1A to E2.  
Furthermore, both steps of intrasplicing should generate specific lariat-branchpoint structures 
representing the excised intronic sequences. Our experimental analysis of the intrasplicing model 
focused on testing these predictions by (1) determining whether a splicing intermediate does 
exist and whether it can function as a direct precursor of mature product, (2) detecting the 
predicted lariat-branchpoint structures from both steps of intrasplicing, and (3) testing the 
function of E1B branchpoint mapped in (2).  
Initial attempts to detect the splicing intermediate in endogenous cellular RNA utilized 
mouse erythroblast RNA as a template for RT-PCR, because this cell type is known to be a rich 
source of 4.1R transcripts. In these experiments we could detect products up to ~3.2kb that 
include much of the intron between E1A and intraexon 1B, and exhibit E1B already spliced to 
E2’/2, exactly as expected. However, full length intermediate failed to amplify, most likely due 
to the large transcript size (~5kb in mouse) and low abundance of this structure. As an alternative 
approach, we turned to the minigene system in which constructs such as pE1A-2 should yield 
smaller intermediates that would be easier to detect by RT-PCR. Indeed, amplification of pE1A-
2 splicing products with primers F1 and R2 generated two predominant products, the unspliced 
precursor and the expected intermediate (Figure 6A). DNA sequence analysis confirmed the 
identity of these bands. It is also worth noting that this PCR assay should also be able to detect 
aberrant products of direct E1A splicing to the default E2 acceptor; the absence of such products 
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reinforces the notion that intraexon E1B is a strong regulator and its presence prevents direct 
splicing of E1A to E2’/2. 
To directly test the functionality of this intermediate RNA, we tested whether it could serve 
as a precursor to mature E1A/E2 product in transfected cells. Figure 6 shows that mouse 3T3 
cells, transfected with human construct E1A-2Lint as the sole source of mature product, indeed 
were able to undertake the hypothesized second step of the reaction to create mature E1A/E2 
product (Figure 6B, lane 3) identical to that obtained by processing of model pre-mRNA pE1A-2 
(lane 2).  No such product was detected in mock transfected cells (lane 4). These findings 
demonstrate that a pre-spliced model of the predicted endogenous intermediate RNA can splice 
in a manner consistent with its proposed role in the intrasplicing pathway for production of 
mature E1A/E2 RNA.   
Detection of predicted lariat structures from both stages of intrasplicing was performed using 
an experimental scheme that facilitates PCR amplification across branchpoint sequences in lariat 
structures (Figure 7A; Vogel et al., 1997). This approach has been used previously to map 
branchpoints for intermediate steps of recursive splicing pathways (Burnette et al., 2005; Hatton 
et al., 1998).  The first step of intrasplicing was hypothesized to involve the E1B 5’ splice site 
looping back to a branchpoint upstream of E2, while the second step was predicted to employ the 
E1A 5’ splice site looping to an E1B-associated branchpoint.  For both steps, nested PCR 
reactions successfully amplified candidate branchpoint structures that were subsequently 
confirmed by DNA sequence analysis (Figure 7B, lanes 2 and 3). As expected, the E1B 5’ splice 
site was joined to a branchpoint located at a fairly typical location (35 bp upstream of the default 
E2 acceptor site), with the sequence TGCTTA*T (asterisk denotes the branchpoint A 
nucleotide).  Interestingly, we determined that the lariat for the second step involved the E1A 5’ 
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splice site looping back to a branchpoint sequence (GTCTCA*C) associated with E1B, 89 nt 
upstream of its junction with E2’, and a total of 106 nt upstream of the distal 3’ splice site in E2 
that is used in the second intrasplicing step (when the 17 nt alternatively spliced portion of E2 is 
taken into account). 
To rule out the possibility that these branchpoints were artifacts of the human minigene 
system, and also to confirm the results in second vertebrate species, we mapped branchpoint 
sequences derived from splicing of endogenous 4.1R pre-mRNAs in mouse erythroblasts.  
Erythroblast RNA was chosen because 4.1R transcripts initiated at E1A are expressed at high 
levels in these cells. Use of nested PCR primers allowed us to successfully amplify branchpoint 
sequences used in both first and second steps of intrasplicing for the mouse 4.1R gene.  DNA 
sequence analysis revealed that the first step branchpoint differs in primary sequence between 
human and mouse, but the approximate location upstream of E2 is conserved.  In contrast, the 
experimentally determined branchpoint used in the second step (GTCTCA*C) was identical in 
the mouse and human genes, both in terms of primary sequence and with respect to its location 
relative to acceptor site SA2 (see also Figure 8 below).  
The functional significance of the conserved intraexon branchpoint was further tested by 
comparing the splicing phenotype of constructs containing the natural branchpoint sequence 
GTCTCA*C, or two mutated branchpoints GTCTCGC and GTCTCGT (Figure 7). Whereas 
positive control construct pE1A-2 was spliced correctly, with E1A joined to the distal acceptor 
(lane 2), both of the branchpoint mutants yielded predominantly inappropriate splicing of E1A to 
the proximal acceptor site (lanes 3 and 4). The presence of incorrectly spliced product indicates 
that the first step of intrasplicing was substantially blocked by the branchpoint mutation, 
consistent with a role for the branchpoint sequence in exon definition prior to the first splicing 
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step. We speculate that the small quantities of properly spliced product result from partial 
utilization of a nearby cryptic branchpoint sequence; cryptic branchpoints have been observed by 
others (Gooding et al., 2006).  
The substantial abrogation of proper E1A splicing to E2 by mutations in critical E1B motifs- 
either the 5’ splice site or its upstream branchpoint- complement the functional analysis of 
splicing intermediates, and together these data strongly support intrasplicing as the bona fide 
major pathway for E1A splicing.  
Conservation of intrasplicing regulatory motifs 
The results above identify two important sub-components of the intraexon: the conserved 
branchpoint region, and the consensus 5’ splice site (Figure 8). Because functional cis-regulatory 
motifs are frequently conserved through evolution, we examined the conservation of these 
intraexon E1B features among mammalian genomes. Comparative genomic analysis of several 
mammals showed that both of these motifs represent islands of highly conserved sequence 
(Figure 8) embedded in a region that is considerably diverged in the flanking introns and only 
moderately conserved in the body of E1B region in a wide variety of mammals. 
 To test whether these sequence properties could facilitate identification of intrasplicing 
elements in other genes, we examined the paralogous 4.1B gene. This gene resembles 4.1R in its 
5’ structure, with multiple promoters/first exons upstream and alternative 3’ splice sites 
downstream in exon 2 (Figure 9A). In the 143kb region between exon 1A and exon 2’/2, only a 
single intrasplicing-like element was identified ~20kb downstream of exon 1A. This element was 
very similar in structure to its counterpart in 4.1R, with candidate distant branchpoint 
/pyrimidine tract motifs, a consensus 5’ splice site, and AG-deficient sequence. Although this 
candidate intraexon is not present in any database transcripts and has not been annotated as an 
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exon, it was able to promote the intrasplicing pathway when positioned downstream of exon 1A 
in the 4.1R minigene (Figure 9B).  Furthermore, mutation of the predicted 5’ splice site of this 
element abrogated its ability to promote intrasplicing (data not shown).   
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Discussion 
Proper E1A splicing proceeds via a two-step mechanism 
This study reports a novel intrasplicing mechanism that coordinates promoter choice with 
downstream splicing events, at alternative splice acceptors, over long distances. In the 4.1R gene 
model, it appears that the location of the promoter, rather than any specific feature of promoter 
sequence, is of paramount importance for intrasplicing: transcripts initiated at promoters 
downstream of the intrasplicing regulatory element splice in a single step to the dominant 
proximal acceptor site in exon 2, while transcripts initiated at promoters upstream of a functional 
intraexon ultimately splice instead to a more distal acceptor site in exon 2. This ability to re-
splice via an ordered two-step mechanism provides a satisfying molecular explanation for the 
otherwise paradoxical long-distance coupling of E1A to the distal acceptor site at E2, a 
phenomenon that is conserved across several vertebrate orders (Tan et al., 2005). To our 
knowledge, this is the first experimentally verified example of intrasplicing. 
Central to the intrasplicing model is the unique behavior of intraexon E1B as an important 
mediator of both splicing steps. This element exhibits dual features of both exons and introns 
embodied among the smaller component motifs that together constitute its structure. In the first 
step the element behaves like an exon (albeit one whose upstream intron is recognized in an AG-
independent manner), providing a strong consensus 5’ splice site that exclusively joins to the 
proximal 3’ splice acceptor at E2’/2. Excision of this extensive intervening sequence changes the 
pre-mRNA architecture substantially by removing not only this internal pair of splice sites, but 
also the branchpoint region naturally located upstream of E2, and juxtaposing E1B with E2’/2. In 
the second step, the E1B branchpoint / pyrimidine sequences are complemented by the distal 
AG-dinucleotide derived from E2’/2 to form a functional composite splice acceptor site. E1B 
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thus behaves like an intron and is deleted in the second step splicing of E1A to E2. In support of 
this model, we have used mutant splicing substrates to demonstrate the importance of the 5’ 
splice site and the juxtaposed branchpoint sequence, mapped branchpoint sequences and 5’ 
splice sites, and provided evidence that the predicted intermediate RNA is a bona fide precursor 
of mature mRNA.  
Although the complex behavior proposed for E1B function in intrasplicing is unusual, there 
is precedence for key aspects of its proposed mechanism of action.  In the first step it appears 
that E1B is recognized as an exon, despite its non-conventional 3’ splice site that lacks an AG-
dinucleotide. AG-independent introns have been shown to be capable of lariat formation (Reed, 
1989); it seems reasonable to propose that exon definition of E1B may occur in a similarly AG-
independent manner, likely promoted by branchpoint/pyrimidine tract binding proteins. The 
absence of an AG is important here because a fully functional 3’ splice site would probably be 
detrimental to the second step of intrasplicing by providing competition with the distal SA2 
acceptor, leading to inclusion of E1B as an internal exon. The necessity of avoiding such 
competition may thus explain the complete absence of AG-dinucleotides in E1B in more than a 
dozen vertebrate genomes examined to date.  Presumably, E1B is recognized through its 
conserved branchpoint/pyrimidine tract, its strong 5’ splice site, and (most likely) exonic splicing 
enhancer elements. In a preliminary scan of the E1B region for potential splicing enhancer 
elements, using ESEfinder (Cartegni et al., 2003), we found that E1B itself was relatively 
enriched in predicted enhancers relative to the flanking introns (results not shown). We speculate 
that splicing enhancer elements are important to prevent premature skipping of the intraexon, 
analogous to the observations that exonic enhancers can act as barriers to prevent inappropriate 
exon skipping (Ibrahim el et al., 2005).  In the second step of intrasplicing, the conserved 
Parra et al., 2007 
17 
branchpoint sequence is relatively distant (106nt upstream) from the juxtaposed internal E2 
acceptor site in the intermediate RNA. How this branchpoint functions at a distance is not clear; 
however, there is precedence for distal branchpoints and AG exclusion zones in a subclass of 
mammalian 3’ splice sites (Gooding et al., 2006). Consistent with this model, the 4.1R and 4.1B 
intraexon sequences are similarly devoid of AG dinucleotides in the branchpoint to 5’ splice site 
region.  
Intrasplicing is distinct from recursive splicing 
 Recursive splicing, a mechanism for stepwise removal of long introns in Drosophila, is 
distinct in its molecular details from intrasplicing.  In recursive splicing, an exon utilizes its 
natural 5’ splice site in a first step to splice to a downstream 3’ splice site AG-dinucleotide in a 
“zero length” exon- so named because the 3’ splice site is immediately adjacent to a 5’ splice site 
with no actual exon sequence between them. Juxtaposition of this 5’ element with the original 
exon thus creates a new composite 5’ splice that allows the exon to splice again to a new 
downstream 3’ splice site.  In contrast, intrasplicing is essentially a situation of nested introns 
with internal and external splice site pairs utilized sequentially. Despite these differences, 
however, we note similarities in the mechanism of recursive splicing and the specific 
intrasplicing pathway described here. Both require participation of regulatory elements- the zero 
length exon or the intraexon- that can be buried deep within introns, and are essential for 
intermediate steps of RNA processing, but are not represented in the mature spliced product. 
Both processes take advantage of the rearrangement of regulatory elements that results from one 
splicing step, to promote the next step of splicing in an orderly process that must require 
dynamic remodeling of the spliceosomal complexes. It will be interesting to explore these 
mechanisms in more detail in the future.  
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Intrasplicing functionally regulates 4.1R protein structure 
The splicing decision at alternative acceptors in E2 directly affects protein 4.1R N-terminal 
structure, because the short 17 nt sequence flanked by these two sites encodes translation 
initiation site AUG1.  During erythroid differentiation, this splicing decision is tied through 
intrasplicing to upstream transcription events to insure synthesis of the functional 80 kDa 
isoforms of the protein. Specifically, 4.1R transcription in late erythroblasts begins almost 
exclusively at E1A (Parra et al., 2003); intrasplicing directs E1A transcripts to skip translation 
start site AUG1; and translation begins predominantly downstream at AUG2 in exon 4 to give 
rise to 80 kDa 4.1R protein. In contrast, other cell types utilize both E1A and E1C to produce a 
mixture of 80 kDa and higher molecular weight isoforms of the protein.  
The preceding analysis suggests also that the original annotation of E1B as an alternative first 
exon in the 4.1R gene should be re-evaluated.  Although standard promoter assays with 
luciferase reporters indicated that the region immediately upstream of E1B possesses promoter 
activity, there is little EST evidence for transcripts initiated at E1B.  We propose instead that the 
major function of E1B is in the intrasplicing pathway, and that E1B will thus be represented 
predominantly in splicing intermediates but not in mature mRNA. 
Other possible roles for intrasplicing 
Intrasplicing could play several distinct roles in processing metazoan pre-mRNAs.  Given the 
abundance of alternative first exons and alternative 3’ splice sites in human genes, intrasplicing 
may offer a new mechanism by which promoter choice can be coupled indirectly to downstream 
alternative splicing. Recent studies in the ENCODE project have demonstrated that distal 5’ 
transcription start sites are not uncommon in the human genome (Denoeud et al., 2007). It is 
interesting to speculate that some of these cases may utilize intrasplicing either to progressively 
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shorten a long first intron, or to couple promoter choice with downstream splicing events as 
demonstrated here for the 4.1R gene. It is important to distinguish this model from other 
coupling mechanisms in which promoter identity can influence transcription rate or splicing 
factor binding activity so as to regulate downstream splicing (Auboeuf et al., 2004; Kornblihtt, 
2005).  The intrasplicing model is unique in that specific promoter characteristics are not 
required, as demonstrated by the ability of heterologous promoters to exhibit proper splicing to 
E2 via this pathway. It appears instead that the physical location of the promoter, upstream of the 
intraexon regulator, is essential for effects on downstream splicing.  
More generally, intrasplicing could be used to regulate alternative 3’ splice sites internally 
within a gene, if a regulatory element similar to the 4.1R intraexon resides upstream of the 
regulated splice site pair. Regulatory control of intrasplicing at such sites could then be mediated 
by antagonistic activities of silencer and enhancer motifs, to inhibit or promote the intrasplicing 
pathway, similar to regulation of tissue-specific alternative exons.  Since a substantial fraction of 
alternative splicing events involve alternative splice donor or splice acceptor sites (Hiller et al., 
2004; Sugnet et al., 2004), this mode of regulation could be more widespread than currently 
appreciated. Such regulation might also explain cases in which use of alternative acceptors does 
not correlate with splice site strength, or diverges from the normal preference for use of the more 
proximal site (Zheng et al., 2005).  Included among the exons that could be regulated by 
intrasplicing are those with the so-called NAGNAG acceptors, in which the alternative 3’ splice 
sites are only three nucleotides apart. Such cases are reported to appear in ~5% of human genes, 
and some may be evolutionarily conserved and tissue specifically regulated (Akerman and 
Mandel-Gutfreund, 2006; Hiller et al., 2004). 
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Finally, intrasplicing has been proposed as a mechanism for aiding the removal of long 
introns (Ott et al., 2003). As many as 10% of human introns are >10kb in length (Sakharkar et 
al., 2005), and intrasplicing could well be adapted for stepwise removal of long introns in other 
genes, somewhat analogous to the ability of recursive splicing to do so (Burnette et al., 2005; 
Hatton et al., 1998).  
 
Materials and Methods 
General molecular biology and splicing assay 
Cloning of the various minigene constructs was performed following standard molecular 
biology protocols (Sambrook et al, 1989).  Restriction enzymes, ligases, and phosphatases were 
obtained from New England Biolabs, while mutagenesis was performed using Stratagene’s 
QuikChange XL Site-Directed Mutagenesis Kit.  Finally, the minigene vector used in this study 
was pcDNA3, supplied by Invitrogen. 
Minigene construction 
Minigene E1A-1 contains the following elements of the human protein 4.1R (EPB41) gene: 
the E1A promoter region, E1A exon sequences, and a short region of downstream intron 
sequence joined to E2 with a short upstream intronic region by an overlapping PCR strategy (in 
the May 2006 version of the human genome assembly, these two regions correspond to 
coordinates chr1: 29,084,660-29,086,576 and chr1:29,186,261-29,187,004, respectively). This 
2.7kb minigene was cloned into the XhoI/XbaI sites of a pcDNA3 vector from which the CMV 
promoter region had been removed by deleting a 740nt region between NruI and EcoRV sites. 
The functional pE1A-2L minigene was constructed by extending the E1A fragment described 
above ~ 7 kb further downstream so as to include E1B and a bit of its downstream intron 
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sequence (chr1: 29,084,660-29,093,166). This construct was further modified by deleting 
substantial portions of the intron sequence between E1A and E1B to generate pE1A-2, pE1A-2a, 
and pE1A-2b. Briefly, pE1A-2 contained only a 200 nt region of E1B (chr1:29092779-
29093001; 223nt) inserted between E1A and E2; pE1A-2a contained a region shifted slightly 
upstream so as to overlap only the 5’ half of E1B (chr1:29,092,690-29,092,909; 219nt); and 
pE1A-2b contained a region shifted slightly downstream so as to overlap only the 3’ half of E1B 
(chr1:29,092,888-29,093,096; 209nt). Minigene pANK-2L is similar to pE1A-2L, except that the 
promoter and first exon of the erythroid ankyrin gene (chr8:41,773,748-41,774,499 in the UCSC 
genome browser) were substituted in place of the 4.1R E1A elements. Minigene pE1C-2L 
likewise substitutes the promoter/first exon of exon 1C from the human 4.1R gene 
(chr1:29,112,211-29,114,244 in the UCSC genome browser) in place of the 4.1R E1A elements. 
Construct pE1A-2Lint is identical to pE1A-2L, except the intron between E1B and E2 is deleted. 
Likewise, pE1A-2int is identical to pE1A-2, except for deletion of the same intron.  
Site-directed mutagenesis 
Mutagenesis of candidate splicing elements was performed using the QuikChange XL Site-
Directed Mutagenesis Kit (Stratagene). The 5’ splice site of E1B was altered from GTGAGT to 
ATGAAT using the primer 5’-GACGGCTGCTTCTGGATGAATAATGG-TTTGACTTAATG-
3’ and its reverse complement. The branchpoint upstream of E1B was mutated from GTCTCAC 
to GTCTCGC using the primer 5’-GGCTGTGCTGTGTGTCTCGCTGCTGTCATTTGCTTCC 
-3’ and its reverse complement. A second mutation to GTCTCGT was performed using primer 
5’-GGCTGTGCTGTGTGTCTCGTTGCTGTCATTTGCTTCCA-3’ and its reverse complement. 
Underlined nucleotides in the primers indicate positions of the mutated nucleotides; bold 
nucleotides indicate normal position of the branchpoint. 
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Splicing analysis 
Minigenes were transfected into mouse 3T3 or human HEK293T cells using Fugene 
Transfection Reagent (Roche) as described (Ponthier et al., 2006). Total RNA was extracted 
from cells with Qiagen’s RNeasy Mini Kit, and then reverse-transcribed into cDNA using the 
Superscript III First Strand Synthesis System (Invitrogen) with a reverse primer targeted 
specifically against the pcDNA3 vector (5’-TACAAGGCACAGTCGAGG-3’).  The following 
primers were used in subsequent PCR assays designed to distinguish between correct and 
incorrect splicing at the alternative splice acceptors at E2: F1 (E1A forward primer) 5’-
GCAAAGTGGCAGGAACCTCTTAAAG-3’; R1 (E2 reverse primer) 5’-
CGAGGAGAATAGTCGTGAAAGTCC-3’; R2 (reverse primer that overlaps E2’/2) 5’-
GTCACTAAACTCTTCTCTGTTGTC-3’; ANK1 forward, 5’-
CTCCTCCTCAAGCCCCCAAG-3’; E1C forward primer is 5'-CTCCTCCTGCCATTGTTCGT-
3'. 
Lariat analyses 
Amplification of lariat intermediates was performed as described (Vogel et al., 1997) and 
diagrammed in Figure 7. To detect the lariat intermediate for the first intrasplicing step joining 
E1B to E2’, the nested PCR reactions were performed with the last step utilizing a forward 
primer located upstream of exon E2’ (5’-GGATGGTATTCGTCCCGGATGGT-3’) and a 
reverse primer downstream of E1B (5’-GCAGTCATTAAGTCAAACCATTA-3’). Similarly, to 
detect the lariat resulting from second step splicing of splicing of E1A to E2, nested PCR 
reactions were again performed using forward primers located upstream of intraexon E1B (final 
primer sequence: 5’-CAGATTATTGCTGACTAGGGCGT-3’) and reverse primers downstream 
of E1A (final primer sequence: 5’-GGACCCTTCGACCCTGGTCTCGC-3’).  As described in 
Parra et al., 2007 
23 
the original report, the PCR product spanning the branch point exhibited a “T” in place of the 
actual branchpoint “A” residue.  In multiple experiments to amplify the branchpoints from low 
abundance pre-mRNAs, we consistently obtained the expected products from the 4.1R gene. 
However, unrelated products with no sequence homology to the 4.1R gene were also sometimes 
amplified and we were unable to completely eliminate these additional artifacts. 
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Figure Legends 
Figure 1. Promoter choice and downstream alternative splicing events in protein 4.1R.  A. 
Arrangement of the 4.1R gene, 5’ region, showing three alternative first exons E1A, E1B, and 
E1C, and the differential manner in which they splice selectively to alternative acceptors 
downstream in E2. The proximal site E2 acceptor is pyrimidine rich and is predicted to be a 
stronger 3’ splice site than the distal, more purine rich, site (Tan et al., 2005); the 17 bp region 
between these acceptors is indicated by E2’. The thin line to E1B indicates that this isoform is 
rare among database clones. Numbers on the introns indicate length in kb. (B) An important 
functional consequence of this splicing variation is that E1A transcripts produce a shorter protein 
isoform compared to that made from E1B/C promoters, with the former missing a critical 
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‘headpiece’ region (HP) that participates in protein-protein interactions. Other protein 4.1R 
domains are indicated by the abbreviations FERM (4.1/ezrin/radixin/moesin homology domain), 
SAB (Spectrin-Actin Binding domain), and CTD (C-Terminal Domain). 
Figure 2. Minigene constructs used to analyze intrasplicing.  Diagrams show the structure of 
minigenes used in this study to map the intrasplicing regulatory element, to test promoter 
dependence of intrasplicing, and to investigate motifs essential for the intrasplicing mechanism. 
Each construct consists of three components derived from the human 4.1R gene: a promoter/first 
exon, a portion of the 4.1R intron downstream of E1A, and a terminal exon consisting of 4.1R 
exon 2 with its proximal upstream intron sequence. Gaps represent regions of the natural gene 
that have been deleted.  Promoter identity is indicated in the construct designation; pE1A, 4.1R 
exon 1A promoter; pCMV, cytomegalovirus promoter; pANK,  erythroid ANK1 promoter 
(Gallagher et al., 2000); and pE1C, 4.1R exon 1C promoter. E1B does not have a consensus 3’ 
splice site; its approximate 5’ boundary is indicated by the dotted line. Constructs pE1A-2b and 
pE1A-2a each contains only half of the E1B region.  In the bottom panel, sites marked by the 
“X” indicate position of mutations in the E1B 5’ splice site and E1B-associated branchpoint; 1B* 
indicates a candidate regulatory element from the paralogous 4.1B gene. 
Figure 3. A downstream regulatory element is required for proper E1A splicing to exon 2 
Analysis of spliced products as a function of the presence of downstream regulatory element(s). 
Shown are the amplified products from cells transfected with the following constructs: lane 1, 
size standards (indicated in nt); lane 2, pE1A-1; lane 3, pE1A-2L; lane 4, pE1A-2; lane 5, pE1A-
2a; lane 6, pE1A-2b. Lane 7 represents a negative PCR control. The larger PCR product 
(expected size=343 nt) corresponds to inappropriate splicing of E1A to the proximal acceptor in 
E2, while the smaller product (expected size=326 nt) represents correct splicing to the distal 
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acceptor.  Correct splicing of transcripts initiated at E1A required a regulatory element in the 
downstream intron that overlaps with E1B.  
Figure 4. Proper E1A splicing is independent of promoter architecture, but requires 
splicing element(s) associated with E1B.  A. Analysis of spliced products as a function of 
promoter identity. Shown are the amplified products from cells transfected with the following 
constructs: lanes 1 and 7, pE1A-2L; lane 2, pCMV-2L; lane 3, pANK-2L; lanes 4 and 6, pE1A-1 
negative control, lanes 5 and 9, mock transfection; lane 8, pE1C-2L. Correct splicing of 
transcripts initiated at promoters upstream of E1B was independent of promoter or first exon 
identity.  B. Dependence of E1A splicing on the E1B 5’ splice site.  Lanes in panel (B) are as 
follows: Lane 1, construct E1A-1 lacking the regulatory element; lane 2, construct E1A-2 with 
an intact E1B 5’ splice site; lane 3, construct E1A-2mut5’ with a mutant E1B 5’ splice site; lane 
4, negative PCR control; lane 5, mock transfected cells.  
Figure 5. The two-step intrasplicing hypothesis.  (A).  In this model, the splice donor site of 
E1B (SD1) splices to the proximal 3’ acceptor of E2 (SA1) in the first step of the reaction, 
resulting in an intermediate and an excised lariat structure.  This step juxtaposes E1B with E2 
and, by eliminating SA1, activates distal acceptor SA2. In the second step, E1B functions as an 
intron so that the E1A 5’ splice site (SD2) splices to SA2 using branchpoint bp2, excising a 
second lariat and releasing the mature product. (B). Top panel shows the sequence context of 
E1B prior to the first step of intrasplicing, when it is preceded by a candidate branchpoint / 
pyrimidine tract and followed by a consensus 5’ splice site. Lower panel shows the sequence 
context after the first step of intrasplicing, when E1B has been juxtaposed to E2’/2 to form a new 
composite 3’ splice site in conjunction with the distal AG-dinucleotide. 
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Figure 6. Analysis of the partially spliced RNA intermediate.  (A) Detection of the 
intermediate RNA produced in the first step of intrasplicing from pE1A-2. RNA from transfected 
cells was amplified by RT-PCR using the indicated primers. (B) Splicing of intermediate RNA 
into mature product. Constructs used for splicing assays: lane 1, pE1A-1 negative control; lane 2, 
pE1A-2L positive control; lane 3, intermediate pE1A-2Lint; lane 4, mock-transfected control. 
Note that the intermediate functions as a direct precursor of the mature E1A-E2 spliced product.  
(C). Detection of a partial splicing intermediate from endogenous RNA.  Natural RNA purified 
from mouse splenic erythroblasts was amplified using an antisense primer at the E2’/2 junction, 
and sense primers in the intron upstream of E1B.  In the longest successful amplification (lane 
1), ~3.2kb of upstream intron was present upstream of the joined E1B/2’/2. Lane 2 represents 
size standards in kb. 
Figure 7. Branchpoint analysis. (A) RT-PCR strategy for detecting lariat intermediates from 
both steps of intrasplicing  (Vogel et al., 1997), showing location of antisense (AS1, AS2) and 
sense (S1, S2) primers. Branchpoint is indicated by “bp”. (B) Gel analysis of the amplified 
branchpoint structures.  Arrows indicate PCR products whose sequences were confirmed to 
represent lariat structures in which upstream 5’ splice sites loop back to the relevant branchpoints 
for both steps of the proposed mechanism. Lane 1, 100 bp size ladder; lane 2, lariat from second 
step of intrasplicing; lane 3, lariat from first step of intrasplicing. The additional band in lane 3 is 
an artifact unrelated to 4.1R transcripts. C. Functional testing of the branchpoint for step 2. Lane 
1, incorrectly spliced product from pE1A-1; lane 2, correctly spliced product from pE1A-2; lanes 
3-4, mixture of spliced products from two different branchpoint mutants; lane 5, mock 
transfection;, lane 6, negative PCR control.  Mutagenesis of the highly conserved branchpoint 
resulted in reduced production of properly spliced E1A transcript. 
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Figure 8. Phylogenetic conservation of the intraexon-associated branchpoint and 5’ splice 
site. (A) Organization of the intrasplicing element, showing the conserved branchpoint located 
84-92 nt upstream of the conserved, consensus 5’ splice site. (B) Comparison of genome 
sequences shows that these two key motifs were conserved in a wide range of mammalian 
species. In the branchpoint sequences, nonconserved nucleotides are underlined and the 
presumed branchpoint A is represented in bold. In the 5’ splice site sequences, upper case 
represents the end of E1B and lower case nucleotides indicate the beginning of the intron.  
Figure 9. Functional analysis of a heterologous intraexon from the paralogous 4.1B gene. 
(A) A candidate intraexon E1B* identified 20kb downstream of exon 1A in the 4.1B gene was 
inserted into the 4.1R minigene in place of the natural element, and tested for its ability to 
promote the intrasplicing pathway. (B). Splicing assay showing that the heterologous element 
does promote proper intrasplicing. 










